# FDA Inspection 1093423 - Regenesis Pharmaceutical Inc. - June 18, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/regenesis-pharmaceutical-inc/394e483e-0160-4b5b-924c-97fa756a7c00
Source feed: FDA_Inspections

> FDA Inspection 1093423 for Regenesis Pharmaceutical Inc. on June 18, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1093423
- Company Name: Regenesis Pharmaceutical Inc.
- Inspection Date: 2019-06-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1093423 - 2019-06-18](https://www.globalkeysolutions.net/records/fda_inspections/regenesis-pharmaceutical-inc/1f1a847c-0ef1-4256-a277-b66b0ac7c64a)

Company: https://www.globalkeysolutions.net/companies/regenesis-pharmaceutical-inc/e74e384c-018e-4735-b2f2-7cf6dd27a8fa

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c